Covington & Burling LLP operates as a limited liability partnership worldwide, with the practice in England and Wales conducted by an affiliated
limited liability multinational partnership, Covington & Burling LLP, which is formed under the laws of the State of Delaware in the United States
and authorized and regulated by the Solicitors Regulation Authority with registration number 77071..
David Wildman specializes in complex transactions involving technology, intellectual property, and data. In this role, he regularly advises clients on issues relating to data commercialization, IP licensing, software development, and information technology services (such as cloud services, IT procurement, and outsourcing). David, who is a registered Patent Attorney and former electrical engineer, also advises on the intellectual property aspects of mergers, acquisitions, and strategic investments. David represents clients in a wide array of industries, including health technology, travel, and finance.
In addition to his broader practice, David is a member of Covington’s Digital Health Initiative. In that capacity, he counsels pharmaceutical, medical device, and technology companies on the complex commercial and intellectual property considerations that arise at the intersection of information technology, life sciences, and healthcare. These considerations include patient privacy and data security, ownership of data and derived insights, service levels, the development and exploitation of “Big Data” analytical tools and predictive models, and FDA-readiness, as well as other commercial issues that arise when entering into a partnership, collaboration or other strategic arrangement with participants in the digital health sector.
David also has extensive experience in the management and strategic development of patent portfolios in a variety of technical disciplines, which he leverages to help clients develop holistic intellectual property strategies that align to business objectives.
Before joining the firm, David worked at another leading law firm prosecuting patent applications in the U.S. and abroad, representing clients in post-grant proceedings at the United States Patent & Trademark Office (USPTO), conducting due diligence analyses, and rendering opinions on patent validity, infringement, and freedom-to-operate. David holds a degree in Electrical Engineering from Columbia University and obtained his J.D. from New York University School of Law. Prior to his legal career, David worked as a wireless design engineer in the mobile device industry.
GlaxoSmithKline on its multi-year drug target discovery and development collaboration with 23andMe.
Teva Pharmaceutical Industries in its strategic partnership with IBM, including the deployment of IBM’s Watson Health Cloud as Teva’s global patient technology platform.
American Airlines in technology and data distribution agreements with travel industry participants.
Various airlines in connection with agency agreements, data commercialization agreements, data distribution agreements, and IT services agreements.
A multinational biopharmaceutical company in connection with an acquisition of a biotechnology company specializing in CRISPR-based technologies for target discovery.
A major pharmaceutical company on its agreements relating to the sequencing of genomic data sets from the UK Biobank.
An emerging digital health company as product counsel for its cancer treatment platform, including the development of template partner and customer agreements.
A cloud services company, with a genome informatics and data management platform, in connection with a gene sequencing collaboration agreement, material transfer agreements and terms for data analytics challenges.
A subsidiary of a major pharmaceutical company in development and collaboration agreements with various EHR platform providers.
A pharmaceutical company in a data licensing agreement with a health analytics firm.
A biotech company in an intellectual property licensing agreement with a product manufacturer.
A pharmaceutical company with its Terms of Service and Privacy Policy for a suite of mobile health apps and websites.
An aerospace company in a licensing dispute with a software vendor.
A travel industry client in connection with IP due diligence and technology transfer and licensing agreements.
Obtained Special Immigrant Juvenile Status (SIJS) for a minor from El Salvador in removal proceedings.
Obtained cancellation of removal for a 30-year legal permanent resident in removal proceedings.
Advised a 501(c)(3) organization in connection with an agreement for customer relationship management (CRM) software and consulting services.
Advised the founder of a fitness company directed at low income individuals on corporate and intellectual property matters, including with respect to entity formation, trademark filings, client agreements, and publicity waivers.
Previous Experience
Performed IP due diligence on behalf of an investor participating in a Series C funding round of a medical device company.
Facilitated the development of a global licensing program, involving thousands of IP assets, for a leading media company.
Represented a Fortune 500 company in an inter partes review at the USPTO.
Back
